KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Twist Bioscience (TWST) Revenue (2017 - 2026)

Twist Bioscience has reported Revenue over the past 10 years, most recently at $110.7 million for Q1 2026.

  • Quarterly Revenue rose 19.31% to $110.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $409.5 million through Mar 2026, up 17.77% year-over-year, with the annual reading at $376.6 million for FY2025, 20.32% up from the prior year.
  • Revenue was $110.7 million for Q1 2026 at Twist Bioscience, up from $103.7 million in the prior quarter.
  • Over five years, Revenue peaked at $110.7 million in Q1 2026 and troughed at $48.1 million in Q1 2022.
  • The 5-year median for Revenue is $75.3 million (2024), against an average of $77.1 million.
  • Year-over-year, Revenue soared 60.24% in 2022 and then increased 13.59% in 2023.
  • A 5-year view of Revenue shows it stood at $54.2 million in 2022, then surged by 31.81% to $71.5 million in 2023, then rose by 24.08% to $88.7 million in 2024, then increased by 16.89% to $103.7 million in 2025, then grew by 6.77% to $110.7 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Revenue are $110.7 million (Q1 2026), $103.7 million (Q4 2025), and $99.0 million (Q3 2025).